This role£46,278 to £53,276estimated · above the range ONS published
UK median£42,079
ONS Annual Survey of Hours and Earnings 2025, full-time gross annual pay, UK.View these figures as a table
ASHE pay percentiles for Other health professionals n.e.c. in UK
Percentile
Pay
10th
£28,606
25th
£34,346
50th
£42,079
75th
£49,077
UK median
£42,079
Sponsorship
Sponsorship chance
Low
·Not matched to a licence on the register
·Occupation is eligible for Skilled Worker
·Estimated salary clears the going rate
On the public records we hold, sponsorship for this role looks unlikely: not matched to a licence on the register, and occupation is eligible for Skilled Worker.
Confidence: medium
The salary is an estimate from national earnings data, not the employer's figure.
Sign in to see how you fit and draft a cover letter
We read this advert for what it asks, check each line against your CV and show you the evidence for every judgement.
Reporting to: VP & Regional Medical Director, Oncology Europe Role overview GSK’s lung oncology portfolio is expanding rapidly in Europe. The Europe Medical Affairs Head, Lung – Oncology is accountable for building the medical foundations for multiple lung indications ahead of first European filings, and for shaping successful launches across the region. This includes developing and activating the external network and strategic partnerships, driving evidence plans tailored to the European context, ensuring country readiness, and providing clear leadership across the matrix. This role is a key member of the Europe Oncology Medical Affairs Leadership Team and reports to the VP & Regional Medical Director, Oncology Europe. It works in close partnership with the Global Medical Franchise Head, the R&D Therapeutic Area Head, and cross-functional regional and country stakeholders. Country medical directors and their teams sit in local markets; the lung strategy is delivered through them, making influence, scientific credibility and collaboration critical to success. Key responsibilities
Lead the European lung medical network
Map and build the lung oncology medical community across Europe, including key external experts and centres.
Define and establish strategic partnerships with cooperative groups, registries, academic centres and patient organisations, selected on their scientific and network impact.
Synthesise insights from the European network into clear regional medical positions and advocate these with global development and evidence teams so that global plans reflect European needs and reality.
Shape evidence for European access
Define early real-world evidence (RWE) needs for lung oncology in Europe, in close collaboration with Access, HTA and global evidence partners.
Lead the development of PICO-aligned evidence strategies in the context of the EU HTA Regulation (HTAR) and mandatory Joint Clinical Assessments (JCA).
Provide regional direction on phase IIIb/IV programmes, collaborative studies and investigator-sponsored research (ISR) in lung, in line with GSK SOPs and governance.
Drive launch readiness across countries
Set the regional medical launch plan per indication and define minimum medical standards and deliverables for each country.
Own the scientific narrative and regional medical plan for lung across indications and lifecycle.
Lead structured readiness reviews against agreed milestones and provide transparent reporting on status, risks and mitigation to regional and global stakeholders.
Information from public records, not immigration advice.
Why
Blocking: Not matched to a licence on the register
We could not match this employer to a licence on the Home Office register. That may mean they hold none, or that they trade under a name the register spells differently.
Home Office register of licensed sponsors
In favour: Occupation is eligible for Skilled Worker
Occupation code 2259 (Other health professionals n.e.c.) is eligible for the Skilled Worker route on the rules in force from 11 Nov 2025.
Immigration Rules Appendix Skilled Occupations
In favour: Estimated salary clears the going rate
No salary is stated, so this uses an estimate of £46,278 from ASHE estimate (low end of the principal band) (1 Apr 2025). It clears the general Skilled Worker salary threshold of £41,700 by £4,578. Because that salary is estimated rather than stated, this rule counts half.
Not established: The advert says nothing about sponsorship
We searched the advert for the usual wording in both directions and found none of it.
The advert itself
Home Office register of licensed sponsors snapshot
Home Office going rates from
Skilled Worker general salary threshold from
ONS Annual Survey of Hours and Earnings from
Licence
Not on the sponsor register
We could not match this employer to a licence on the Home Office register. That may mean they hold none, or that they trade under a name the register spells differently.
Home Office register of licensed sponsors snapshot
Going-rate check
We hold no going rate for occupation code 2259.
Information from public records, not immigration advice.
Lead and influence through the matrix
Provide functional leadership to country medical leads in lung oncology, aligning local execution with the regional strategy.
Partner closely with Commercial, Market Access, Regulatory, R&D and Global Medical at regional and country level, driving alignment and consensus rather than directive control.
Communicate clear, evidence-based positions on contested or complex topics to senior management and scientific audiences, explicitly stating counter-arguments and evidence gaps.
Coach and develop country medical colleagues in external engagement, insight generation and scientific exchange, building lung capability across the European organisation as the portfolio grows.
Identify, develop and retain medical talent across Europe.
Ensure medical governance and compliance
Hold overall medical governance and fair-balance oversight for all lung oncology medical activities in Europe.
Ensure adherence to GSK policies, SOPs and local regulations, proactively identifying and escalating issues and risks.
Basic qualifications
Medical Doctor (MD) with board certification or equivalent clinical and industry experience in oncology.
7+ years of experience in the pharmaceutical industry in oncology medical affairs; lung cancer experience is essential, experience in other solid tumours is an advantage.
Demonstrated European launch experience, including pre-launch, launch and post-launch phases for at least one first-in-market indication.
Experience in regional or global medical roles, or senior in-country roles with clear global exposure.
Proven track record of external engagement with oncology experts, cooperative groups and congresses, with evidence of translating insights into strategy and/or evidence generation decisions.
Working knowledge of HTA and evidence planning in Europe, including practical understanding of HTAR and JCA implications.
Fluent in written and spoken English; an additional European language is an advantage.
Preferred qualifications & skills
PhD or PharmD in a relevant scientific discipline.
Established, active network in lung oncology across Europe.
Demonstrated agility in building country medical plans, developing evidence strategies and delivering successful launches.
Deep subject matter expertise in lung cancer.
Strong understanding of access and commercial considerations, including comfort with indication-level KPIs, forecasting and launch economics.
High level of technology fluency and ability to use digital tools to drive insight generation, collaboration and execution.
Proven matrix and indirect leadership skills, with a track record of building trust and influence across functions, geographies and cultures.
What the role offers
End-to-end ownership of a key therapy area in Europe, from pre-launch through launch, post-launch optimisation and into future pipeline indications.
Exposure and collaboration with senior stakeholders across R&D, Medical, Commercial and Access, with direct accountability for performance in European countries.
Opportunity to shape evidence strategies and external partnerships in a priority growth area for GSK Oncology.
A leadership team and culture that value robust debate, scientific excellence and clear, well-argued positions.
Why GSK GSK has taken bold steps into oncology, investing significantly in science, talent and pipeline. Lung cancer is central to our European oncology strategy. Our culture is grounded in being ambitious for patients, accountable for impact and doing the right thing, underpinned by our values of transparency, respect, integrity and patient focus in how our medical organisation operates. If this sounds like the next step you want to take in your career, we would be pleased to explore the opportunity with you. Skills Cross-Functional Leadership, Digital Fluency, Enterprise Thinking, High Impact Communication, Launch Excellence, Patient Impact
Why GSK? Uniting science, technology and talent to get ahead of disease together.
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.
People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.
GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.
We believe in an agile working culture for all our roles. If flexibility is important to you, we encourage you to explore with our hiring team what the opportunities are.
Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us at UKRecruitment.Adjustments@gsk.com where you can also request a call.
Please note should your enquiry not relate to adjustments, we will not be able to support you through these channels. However, we have created a Recruitment FAQ guide. Click the link where you will find answers to multiple questions we receive
Important notice to Employment businesses/ Agencies GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.
Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information, please visit the Centers for Medicare and Medicaid Services (CMS) website at https://openpaymentsdata.cms.gov/
Read from the employer’s own job board (workday) on